{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T16:49:28Z","timestamp":1787503768604,"version":"build-2736575974"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,7]],"date-time":"2022-01-07T00:00:00Z","timestamp":1641513600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008069","name":"University of California, San Francisco","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008273","name":"Novartis Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008273","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000691","name":"Novartis Foundation","doi-asserted-by":"publisher","award":["A122666"],"award-info":[{"award-number":["A122666"]}],"id":[{"id":"10.13039\/501100000691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["OPP1160129"],"award-info":[{"award-number":["OPP1160129"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eClinicalMedicine"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.eclinm.2022.101272","type":"journal-article","created":{"date-parts":[[2022,2,13]],"date-time":"2022-02-13T23:01:57Z","timestamp":1644793317000},"page":"101272","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Serological evaluation of the effectiveness of reactive focal mass drug administration and reactive vector control to reduce malaria transmission in Zambezi Region, Namibia: Results from a secondary analysis of a cluster randomised trial"],"prefix":"10.1016","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6552-3716","authenticated-orcid":false,"given":"Lindsey","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle S.","family":"Hsiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa M.","family":"Prach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leah","family":"Schrubbe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry","family":"Ntuku","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mi-Suk Kang","family":"Dufour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brooke","family":"Whittemore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valerie","family":"Scott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joy","family":"Yala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn W.","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catriona","family":"Patterson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Biggs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"Hall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin K.A.","family":"Tetteh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cara Smith","family":"Gueye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryan","family":"Greenhouse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Bennett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer L.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stark","family":"Katokele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petrina","family":"Uusiku","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davis","family":"Mumbengegwi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roly","family":"Gosling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Drakeley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Immo","family":"Kleinschmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.eclinm.2022.101272_bib0001","doi-asserted-by":"crossref","first-page":"e701","DOI":"10.1016\/S2214-109X(20)30541-6","article-title":"The role and challenges of cluster randomised trials for global health","volume":"9","author":"Dron","year":"2021","journal-title":"Lancet Glob Heal"},{"key":"10.1016\/j.eclinm.2022.101272_bib0002","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000304","article-title":"Stable and unstable malaria hotspots in longitudinal cohort studies in Kenya","volume":"7","author":"Bejon","year":"2010","journal-title":"PLoS Med"},{"key":"10.1016\/j.eclinm.2022.101272_bib0003","first-page":"1","article-title":"Treatment-seeking rates in malaria endemic countries","volume":"15","author":"Battle","year":"2016","journal-title":"Malar. J. 2016 151"},{"key":"10.1016\/j.eclinm.2022.101272_bib0004","doi-asserted-by":"crossref","first-page":"e271","DOI":"10.1371\/journal.pmed.0030271","article-title":"Improving imperfect data from health management information systems in africa using space\u2013time geostatistics","volume":"3","author":"Gething","year":"2006","journal-title":"PLOS Med"},{"key":"10.1016\/j.eclinm.2022.101272_bib0005","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001142","article-title":"Worldwide incidence of malaria in 2009: estimates, time trends, and a critique of methods","volume":"8","author":"Cibulskis","year":"2011","journal-title":"PLOS Med"},{"key":"10.1016\/j.eclinm.2022.101272_bib0006","doi-asserted-by":"crossref","first-page":"246","DOI":"10.4269\/ajtmh.2007.77.246","article-title":"Parasite prevalence: a static measure of dynamic infections","volume":"77","author":"O'Meara","year":"2007","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.eclinm.2022.101272_bib0007","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1093\/infdis\/jiv596","article-title":"Numerical distributions of parasite densities during asymptomatic malaria","volume":"213","author":"Imwong","year":"2016","journal-title":"J Infect Dis"},{"key":"10.1016\/j.eclinm.2022.101272_bib0008","article-title":"Effectiveness and safety of reactive focal mass drug administration (rfMDA) using dihydroartemisinin\u2013piperaquine to reduce malaria transmission in the very low-endemic setting of Eswatini: a pragmatic cluster randomised controlled trial","volume":"6","author":"Vilakati","year":"2021","journal-title":"BMJ Glob Heal"},{"key":"10.1016\/j.eclinm.2022.101272_bib0009","doi-asserted-by":"crossref","first-page":"5108","DOI":"10.1073\/pnas.0408725102","article-title":"Estimating medium- and long-term trends in malaria transmission by using serological markers of malaria exposure","volume":"102","author":"Drakeley","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.eclinm.2022.101272_bib0010","doi-asserted-by":"crossref","first-page":"e25137","DOI":"10.1371\/journal.pone.0025137","article-title":"Serological markers suggest heterogeneity of effectiveness of malaria control interventions on Bioko Island, equatorial Guinea","volume":"6","author":"Cook","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.eclinm.2022.101272_bib0011","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s12936-017-1701-7","article-title":"Serology reveals heterogeneity of Plasmodium falciparum transmission in northeastern South Africa: implications for malaria elimination","volume":"16","author":"Biggs","year":"2017","journal-title":"Malar. J"},{"key":"10.1016\/j.eclinm.2022.101272_bib0012","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1186\/s12916-020-01724-5","article-title":"Antibody responses to a suite of novel serological markers for malaria surveillance demonstrate strong correlation with clinical and parasitological infection across seasons and transmission settings in The Gambia","volume":"18","author":"Wu","year":"2020","journal-title":"BMC Med"},{"key":"10.1016\/j.eclinm.2022.101272_bib0013","first-page":"1","article-title":"Community-based molecular and serological surveillance of subclinical malaria in Myanmar","volume":"19","author":"O'Flaherty","year":"2021","journal-title":"BMC Med. 2021 191"},{"key":"10.1016\/j.eclinm.2022.101272_bib0014","doi-asserted-by":"crossref","first-page":"392","DOI":"10.3201\/eid1603.090732","article-title":"Serologic markers for detecting malaria in areas of low endemicity, Somalia, 2008","volume":"16","author":"Bousema","year":"2010","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.eclinm.2022.101272_bib0015","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1038\/ncomms2241","article-title":"Factors determining the occurrence of submicroscopic malaria infections and their relevance for control","volume":"3","author":"Okell","year":"2012","journal-title":"Nat Commun"},{"key":"10.1016\/j.eclinm.2022.101272_bib0016","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s12879-016-2164-0","article-title":"Effectiveness of a serological tool to predict malaria transmission intensity in an elimination setting","volume":"17","author":"Dewasurendra","year":"2017","journal-title":"BMC Infect. Dis"},{"key":"10.1016\/j.eclinm.2022.101272_bib0017","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0065-308X(09)69005-9","article-title":"Chapter 5. Potential contribution of sero-epidemiological analysis for monitoring malaria control and elimination: historical and current perspectives","volume":"69","author":"Drakeley","year":"2009","journal-title":"Adv Parasitol"},{"key":"10.1016\/j.eclinm.2022.101272_bib0018","year":"2021","journal-title":"World Malaria Report 2021"},{"key":"10.1016\/j.eclinm.2022.101272_bib0019","unstructured":"Elimination 8; Southern African Development Community (SADC). Elimination 8 Annual Report 2016. (2016)."},{"key":"10.1016\/j.eclinm.2022.101272_bib0020","first-page":"546","article-title":"An investigation of the Plasmodium falciparum malaria epidemic in Kavango and Zambezi regions of Namibia in 2016","volume":"112","author":"Chanda","year":"2018","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.eclinm.2022.101272_bib0021","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1016\/S0140-6736(20)30470-0","article-title":"Effectiveness of reactive focal mass drug administration and reactive focal vector control to reduce malaria transmission in the low malaria-endemic setting of Namibia: a cluster-randomised controlled, open-label, two-by-two factorial design trial","volume":"395","author":"Hsiang","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.eclinm.2022.101272_bib0022","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1186\/s12916-020-01785-6","article-title":"Sero-epidemiological evaluation of malaria transmission in The Gambia before and after mass drug administration","volume":"18","author":"Wu","year":"2020","journal-title":"BMC Med"},{"key":"10.1016\/j.eclinm.2022.101272_bib0023","doi-asserted-by":"crossref","first-page":"E4438","DOI":"10.1073\/pnas.1501705112","article-title":"Novel serologic biomarkers provide accurate estimates of recent Plasmodium falciparum exposure for individuals and communities","volume":"112","author":"Helb","year":"2015","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.eclinm.2022.101272_bib0024","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1091\/mbc.e02-04-0240","article-title":"etramps, a new Plasmodium falciparum gene family coding for developmentally regulated and highly charged membrane proteins located at the parasite-host cell interface","volume":"14","author":"Spielmann","year":"2003","journal-title":"Mol Biol Cell"},{"key":"10.1016\/j.eclinm.2022.101272_bib0025","unstructured":"University of California, S.F. Evaluation of targeted parasite elimination (TPE) in Namibiae. ClinicalTrials.cov Available at: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02610400."},{"key":"10.1016\/j.eclinm.2022.101272_bib0026","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2017-019294","article-title":"Study protocol for a cluster randomised controlled factorial design trial to assess the effectiveness and feasibility of reactive focal mass drug administration and vector control to reduce malaria transmission in the low endemic setting of Namibia","volume":"8","author":"Medzihradsky","year":"2018","journal-title":"BMJ Open"},{"key":"10.1016\/j.eclinm.2022.101272_bib0027","series-title":"National Malaria Case Management Guidelines","year":"2014"},{"key":"10.1016\/j.eclinm.2022.101272_bib0028","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1186\/s12936-021-03679-1","article-title":"Community acceptance of reactive focal mass drug administration and reactive focal vector control using indoor residual spraying, a mixed-methods study in Zambezi region, Namibia","volume":"20","author":"Roberts","year":"2021","journal-title":"Malar J"},{"key":"10.1016\/j.eclinm.2022.101272_bib0029","doi-asserted-by":"crossref","first-page":"26","DOI":"10.12688\/wellcomeopenres.14950.1","article-title":"Optimisation and standardisation of a multiplex immunoassay of diverse Plasmodium falciparum antigens to assess changes in malaria transmission using sero-epidemiology","volume":"4","author":"Wu","year":"2019","journal-title":"Wellcome Open Res"},{"key":"10.1016\/j.eclinm.2022.101272_bib0030","unstructured":"Nibsc. First WHO reference reagent for anti-malaria (Plasmodium falciparum) human serum."},{"key":"10.1016\/j.eclinm.2022.101272_bib0031","doi-asserted-by":"crossref","first-page":"2544","DOI":"10.1093\/cid\/ciz740","article-title":"Serologic markers of previous malaria exposure and functional antibodies inhibiting parasite growth are associated with parasite kinetics following a plasmodium falciparum controlled human infection","volume":"70","author":"Achan","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.eclinm.2022.101272_bib0032","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1093\/infdis\/jiu225","article-title":"Estimation of recent and long-term malaria transmission in a population by antibody testing to multiple plasmodium falciparum antigens","volume":"210","author":"Ondigo","year":"2014","journal-title":"J Infect Dis"},{"key":"10.1016\/j.eclinm.2022.101272_bib0034","doi-asserted-by":"crossref","unstructured":"Wu, L. et\u00a0al. Sero-epidemiological evaluation of malaria transmission in The Gambia before and after mass drug administration. medRxiv 2020.04.09.20059774 (2020). https:\/\/doi.org\/10.1101\/2020.04.09.20059774.","DOI":"10.1101\/2020.04.09.20059774"},{"key":"10.1016\/j.eclinm.2022.101272_bib0035","doi-asserted-by":"crossref","first-page":"26","DOI":"10.12688\/wellcomeopenres.14950.1","article-title":"Optimisation and standardisation of a multiplex immunoassay of diverse Plasmodium falciparum antigens to assess changes in malaria transmission using sero-epidemiology","volume":"4","author":"Wu","year":"2019","journal-title":"Wellcome Open Res"},{"key":"10.1016\/j.eclinm.2022.101272_bib0036","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1093\/infdis\/jiu225","article-title":"Estimation of recent and long-term malaria transmission in a population by antibody testing to multiple plasmodium falciparum antigens","volume":"210","author":"Ondigo","year":"2014","journal-title":"J Infect Dis"},{"key":"10.1016\/j.eclinm.2022.101272_bib0037","doi-asserted-by":"crossref","first-page":"5108","DOI":"10.1073\/pnas.0408725102","article-title":"Estimating medium- and long-term trends in malaria transmission by using serological markers of malaria exposure","volume":"102","author":"Drakeley","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.eclinm.2022.101272_bib0038","series-title":"Cluster Randomised Trials","author":"Hayes","year":"2009"},{"key":"10.1016\/j.eclinm.2022.101272_bib0039","doi-asserted-by":"crossref","DOI":"10.2196\/20904","article-title":"Mass drug administration with high-dose ivermectin and dihydroartemisinin-piperaquine for malaria elimination in an area of low transmission with high coverage of malaria control interventions: protocol for the massiv cluster randomized clinical trial","volume":"9","author":"Dabira","year":"2020","journal-title":"JMIR Res. Protoc"},{"key":"10.1016\/j.eclinm.2022.101272_bib0040","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2019-035433","article-title":"Seasonal malaria vaccination: protocol of a phase 3 trial of seasonal vaccination with the RTS,S\/AS01E vaccine, seasonal malaria chemoprevention and the combination of vaccination and chemoprevention","volume":"10","author":"Chandramohan","year":"2020","journal-title":"BMJ Open"},{"key":"10.1016\/j.eclinm.2022.101272_bib0041","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2011\/608719","article-title":"Estimating prevalence using an imperfect Test","volume":"2011","author":"Diggle","year":"2011","journal-title":"Epidemiol Res Int"},{"key":"10.1016\/j.eclinm.2022.101272_bib0042","doi-asserted-by":"crossref","first-page":"131","DOI":"10.12688\/gatesopenres.12897.1","article-title":"Priority use cases for antibody-detecting assays of recent malaria exposure as tools to achieve and sustain malaria elimination","volume":"3","author":"Greenhouse","year":"2019","journal-title":"Gates Open Res"},{"key":"10.1016\/j.eclinm.2022.101272_bib0043","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/s12936-017-1719-x","article-title":"Malaria risk in young male travellers but local transmission persists: a case\u2013control study in low transmission Namibia","volume":"16","author":"Smith","year":"2017","journal-title":"Malar J"},{"key":"10.1016\/j.eclinm.2022.101272_bib0044","doi-asserted-by":"crossref","DOI":"10.1186\/s13063-017-2249-0","volume":"18","author":"Bridges","year":"2017","journal-title":"Trials"},{"key":"10.1016\/j.eclinm.2022.101272_bib0045","doi-asserted-by":"crossref","first-page":"e60780","DOI":"10.1371\/journal.pone.0060780","article-title":"Genetic surveillance detects both clonal and epidemic transmission of malaria following enhanced intervention in Senegal","volume":"8","author":"Daniels","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.eclinm.2022.101272_bib0046","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1093\/infdis\/jiz305","article-title":"High genetic diversity of plasmodium falciparum in the low-transmission setting of the kingdom of eswatini","volume":"220","author":"Roh","year":"2019","journal-title":"J Infect Dis"},{"key":"10.1016\/j.eclinm.2022.101272_bib0047","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1038\/s41591-020-0841-4","article-title":"Development and validation of serological markers for detecting recent Plasmodium vivax infection","volume":"26","author":"Longley","year":"2020","journal-title":"Nat Med"},{"key":"10.1016\/j.eclinm.2022.101272_bib0048","doi-asserted-by":"crossref","unstructured":"Yman, V. et\u00a0al. Distinct kinetics in antibody responses to 111 Plasmodium falciparum antigens identifies novel serological markers of recent malaria exposure. medRxiv (2020).","DOI":"10.1101\/2020.12.14.20242768"},{"key":"10.1016\/j.eclinm.2022.101272_bib0049","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.4269\/ajtmh.18-0303","article-title":"Taking sharper pictures of Malaria with CAMERAs: combined antibodies to measure exposure recency assays","volume":"99","author":"Greenhouse","year":"2018","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.eclinm.2022.101272_bib0050","unstructured":"Immunization, vaccines and biologicals a guide to the design and conduct of dengue serosurveys. (2017)."},{"key":"10.1016\/j.eclinm.2022.101272_bib0051","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0008316","article-title":"The use of serology for trachoma surveillance: current status and priorities for future investigation","volume":"14","author":"Martin","year":"2020","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.eclinm.2022.101272_bib0052","doi-asserted-by":"crossref","first-page":"15","DOI":"10.4269\/ajtmh.17-0371","article-title":"Use of antibody tools to provide serologic evidence of elimination of lymphatic filariasis in the Gambia","volume":"98","author":"Won","year":"2018","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.eclinm.2022.101272_bib0053","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0005616","article-title":"Measuring changes in transmission of neglected tropical diseases, malaria, and enteric pathogens from quantitative antibody levels","volume":"11","author":"Arnold","year":"2017","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.eclinm.2022.101272_bib0054","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.3201\/eid2407.171928","article-title":"Integrated serologic surveillance of population immunity and disease transmission","volume":"24","author":"Arnold","year":"2018","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.eclinm.2022.101272_bib0055","unstructured":"A cluster-randomized trial to evaluate the efficacy of Wolbachia-Infected Aedes Aegypti mosquitoes in reducing the incidence of arboviral infection in Brazil (EVITA Dengue). Available at: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04514107. Accessed 22 February 2021."},{"key":"10.1016\/j.eclinm.2022.101272_bib0056","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.4269\/ajtmh.18-0315","article-title":"Baseline characterization of dengue epidemiology in Yogyakarta City, Indonesia, before a randomized controlled trial of wolbachia for arboviral disease control","volume":"99","author":"Indriani","year":"2018","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.eclinm.2022.101272_bib0057","doi-asserted-by":"crossref","DOI":"10.3390\/tropicalmed4020068","article-title":"Serologic tools and strategies to support intervention trials to combat Zika virus infection and disease","volume":"4","author":"Collins","year":"2019","journal-title":"Trop Med Infect Disease"}],"container-title":["eClinicalMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589537022000025?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589537022000025?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T19:09:41Z","timestamp":1762888181000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589537022000025"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":56,"alternative-id":["S2589537022000025"],"URL":"https:\/\/doi.org\/10.1016\/j.eclinm.2022.101272","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2021.04.12.21255334","asserted-by":"object"}]},"ISSN":["2589-5370"],"issn-type":[{"value":"2589-5370","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Serological evaluation of the effectiveness of reactive focal mass drug administration and reactive vector control to reduce malaria transmission in Zambezi Region, Namibia: Results from a secondary analysis of a cluster randomised trial","name":"articletitle","label":"Article Title"},{"value":"eClinicalMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eclinm.2022.101272","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101272"}}